Gagnon Advisors, LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Gagnon Advisors, LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,532,555
-23.4%
180,3310.0%4.63%
-4.3%
Q2 2023$7,225,863
-1.8%
180,3310.0%4.84%
-2.1%
Q1 2023$7,359,308
+5.7%
180,3310.0%4.94%
+5.1%
Q4 2022$6,962,579
-27.4%
180,3310.0%4.70%
-24.3%
Q3 2022$9,592,000
-30.1%
180,331
-23.4%
6.21%
-25.3%
Q2 2022$13,726,000
-28.4%
235,445
-6.2%
8.31%
-5.8%
Q1 2022$19,167,000
+26.8%
251,1400.0%8.83%
+47.1%
Q4 2021$15,111,000
+12.4%
251,140
+4.6%
6.00%
+12.5%
Q3 2021$13,448,000
+3.9%
240,142
+12.6%
5.33%
+8.5%
Q2 2021$12,938,000
-4.8%
213,217
+10.0%
4.92%
-12.1%
Q1 2021$13,588,000
+17.1%
193,8600.0%5.59%
+7.3%
Q4 2020$11,601,000
-0.5%
193,8600.0%5.22%
-27.1%
Q3 2020$11,655,000
+14.6%
193,8600.0%7.15%
-2.3%
Q2 2020$10,172,000
+56.5%
193,8600.0%7.32%
+20.7%
Q1 2020$6,500,000
-26.0%
193,8600.0%6.06%
+23.2%
Q4 2019$8,782,000
+19.0%
193,8600.0%4.92%
+7.6%
Q3 2019$7,380,000
+58.0%
193,860
+80.5%
4.58%
+71.6%
Q2 2019$4,671,000107,4122.67%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders